Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry

NCT03110432 · clinicaltrials.gov ↗

COMPLETED

Status

1695

Enrollment

OTHER

Sponsor class

Conditions

Dyslipoproteinemias
Hypercholesterolemia, Familial
Familial Hypercholesterolemia - Homozygous
Familial Combined Hyperlipidemia

Interventions

DRUG: PCSK9 Inhibitor [EPC]
DRUG: Standard lipid lowering therapy

Sponsor

GWT-TUD GmbH